CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNITIES

90 min. WEBINAR | By registration only

CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNITIES
Date: 05.02.2024
Time: 5 PM CET
Location: Online

WHAT TO EXPECT

ARENSIA invites you to a 90 min. online session focusing on the thriving clinical trials landscape in Ukraine.
Ukraine is witnessing a resurgence of activities from major pharmaceutical and biotech firms, involving both ongoing and new studies. This aligns with the broader strategy of large pharmaceutical corporations, aiming to enhance inclusivity and extend their reach to underserved populations. In an effort to stimulate clinical trial activities, Ukrainian Health Authorities have recently streamlined legislation, notably reducing the overall approval timeline to just 35 days.
Kyiv remains a secure hub for clinical trials, with all systems operating seamlessly for over a year, including local on-site monitoring, laboratories, courier services, and vendors for imaging.
Despite the conflict starting in February 2022, ARENSIA clinics in downtown Kyiv have maintained full operations, achieving exceptional patient enrollment rates while ensuring data quality and safety.
Join us for insights from esteemed speakers representing Health Authorities, Sponsors, global CROs, andlogistics companies on launching and managing clinical trials in Ukraine.

AGENDA

  • 10 min: Welcome and Introduction
    • Claudia Hesselmann, Founder & CEO, ARENSIA EXPLORATORY MEDICINE Germany
  • 20 min: Status Quo of the clinical research environment in Ukraine
    • Mykhailo Lobas, MD, PhD, Deputy Director of State Expert Committee, Ukraine Ministry of Health
    • Taisa Herasymchuk, PhD, Director of the Preclinical and Clinical Trial Materials Expert Evaluation Department
    • Sergii Rasputniak, MD, Head of GLP, GCP Audit Department
  • 15 min: ARENSIA research clinic: Insights into operational aspects of studies conduct
    • Evgeny Levenko, MD, PhD, Country Manager, ARENSIA Clinics, Kyiv, Ukraine
  • 45 min: Panel discussion: status quo & aspects to consider when resuming or planning new clinical trials in Ukraine
    • Moderator: Evgeny Levenko
    • Mykhailo Lobas, Taisa Herasymchuk, Sergii Rasputniak
    • Steve Whitaker, Vice President Clinical Development, Omeros Corporation
    • Oleg Karpenko, MD, Senior Operational Clinical Manager, Fortre
    • Olena Skyba, Country Manager World Courier (Cencora)
  • Requirements and timelines for approval of clinical trials in Ukraine
  • Risk-benefit assessment of running clinical trials in Ukraine
  • In and outbound shipments of study supplies
  • Use of technology advancements/remote solutions as a mitigation plan
CONTACT US

This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about the traffic in our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. Detailed information about the use of necessary cookies, which are essential to browse this website, and optional cookies, which you can select below, and how you can review or withdraw your consent at any time can be found in our Privacy Statement.

Always ON Essentials

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

  • cookiePreference

    This essential functionality ensures that your choices regarding data privacy and personalization are respected and consistently applied during your visits. You can seamlessly navigate our website with the confidence that your selected settings are in place, providing a tailored and secure user experience.

    Expiry: 1 year Type: Local
  • cookiePreference-*

    This cookie is an advanced component of our website, meticulously designed to track and manage the specific categories of cookies you allow. This innovative functionality ensures that your customized cookie settings are precisely implemented, offering a seamless and personalized browsing experience that aligns with your privacy preferences.

    Expiry: 1 year Type: Local
Statistics

Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.

  • Google Analytics

    We create pseudonymous user profiles with the help of Google Analytics in order to design our websites in line with requirements. Google Analytics uses targeting cookies that are stored on your end device and can be read by us. In this way, we are able to recognize and count returning visitors and find out how often our websites are accessed by different users. Data processing is carried out on the basis of Art. 6 para. 1 lit. a) GDPR (consent) and § 25 para. 1 TDDDG. The information generated by the cookie about your use of our website is usually transmitted to a Google server in the USA and stored there. However, since we have activated IP anonymization on our website, your IP address will be shortened by Google beforehand within member states of the European Union. Only in exceptional cases will the full IP address be transmitted to a Google server in the USA and only shortened there (further information on the purpose and scope of data collection can be found, for example, at https://policies.google.com/privacy?hl=de&gl=de). We have also concluded an order processing contract with Google LLC (USA) in accordance with Art. 28 GDPR. Google will therefore only use all information strictly for the purpose of evaluating the use of our websites for us and compiling reports on website activity.

    _ga_

    This cookie is used by Google Analytics to persist session state.

    Expiry: 1 year 1 month Type: Third-party
    _ga

    This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports.

    Expiry: 1 year 1 month Type: Third-party
  • Hotjar

    We use Hotjar Observe, a service provided by Hotjar Ltd, 3 Lyons Range, 20 Bisazza Street, Sliema SLM 1640, Malta, on our website. This is a software for the analysis and optimization of online offers on the basis of pseudonymous measurements and analyses of user behavior, which may include in particular A/B tests (measurement of the popularity and user-friendliness of different content and functions), measurement of click paths and interaction with content and functions of the online offer (so-called heat maps and recordings). The legal basis is your consent in accordance with Art. 6 para. 1 lit. a) GDPR and Section 25 para. 1 TDDDG.

    _hjSessionUser_*

    Set when a user first lands on a page. Ensures data from subsequent visits to the same site are attributed to the same user ID. Persists the Hotjar User ID which is unique to that site. Hotjar does not track users across different sites.

    Expiry: 1 year Type: Third-party
    _hjSession_*

    Holds current session data. Ensures subsequent requests in the session window are attributed to the same session.

    Expiry: 1 hour Type: Third-party
  • Zoom Info

    We use the advertising services of ZoomInfo for our website. The service provider is the Canadian company ZoomInfo Technologies LLC, 805 Broadway, Suite 900, Vancouver, WA 98660, Canada. Your data may also be processed in Canada and thus outside the scope of the GDPR. The European Commission has decided that there is an adequate level of protection for commercial offers from Canada in accordance with Art. 45 para. 1 GDPR. This means that data transfer to this country is permitted.

    __cf_bm

    This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.

    Expiry: 30 minutes Type: Third-party
    _zitok

    First-party cookie set by ZoomInfo to identify unique visitors.

    Expiry: 1 year Type: Third-party
    _cfuvid

    The _cfuvid cookie is used to allow the Cloudflare WAF to distinguish individual users who share the same IP address. Visitors who do not provide the cookie are likely to be grouped together and may not be able to access the site if there are many other visitors from the same IP address.

    Expiry: Session Type: Third-party
Marketing

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

  • Linkedin

    Our website uses the “LinkedIn Insight Tag” conversion tool from LinkedIn Ireland Unlimited Company, Wilton Place, Dublin 2, Ireland.This tool creates a cookie in your web browser, which enables the following data to be collected: IP address, device and browser characteristics and page events (e.g. page views). This data is encrypted, anonymized within seven days and the anonymized data is deleted within 90 days. LinkedIn does not share any personal data with us, but offers anonymized reports on the website target group and display performance. LinkedIn also offers the option of retargeting via the Insight Tag.

    AnalyticsSyncHistory

    Used to store information about the time a sync with the lms_analytics cookie took place for users in the Designated Countries.

    Expiry: 1 month Type: Third-party
    li_gc

    Used to store guest consent to the use of cookies for non-essential purposes

    Expiry: 6 months Type: Third-party
    lidc

    Facilitates data center selection.

    Expiry: 1 day Type: Third-party
    UserMatchHistory

    This cookie is used to track visitors so that more relevant ads can be presented based on the visitor's preferences.

    Expiry: 1 month Type: Third-party
    bscookie

    Used for remembering that a logged in user is verified by two factor authentication and has previously logged in.

    Expiry: 1 year Type: Third-party
    bcookie

    Browser Identifier cookie to uniquely identify devices accessing LinkedIn to detect abuse on the platform .

    Expiry: 1 year Type: Third-party
    li_sugr

    Used to make a probabilistic match of a user's identity.

    Expiry: 3 months Type: Third-party
Allow all Allow selection Deny